Tallac Therapeutics Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - Burlingame, USA
Description -
Tags - Receptor Agonist Antibody Conjugate TRAAC Receptor Agonist Antibody Conjugate TLR9 CpG
Team
Founder Hong I Wan
Founder
Funding
Tallac Therapeutics raised $62,000,000 with Bio Partners and Lightstone Ventures and Matrix Partners China, MRL Ventures Fund, Morningside Venture - 12/1/2020